3M’s “Forever Chemicals” Bill Just Grew by Billions
3M just turned its biggest open PFAS lawsuit into a payment schedule, but whether that deal actually holds depends on a participation threshold the company has not yet disclosed publicly.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
On November 3, 2026, 3M (NYSE:MMM | MMM Price Prediction) agreed to a pre-tax nominal commitment of $7.35 billion over nine years to settle personal injury claims over AFFF firefighting foam. The deal covers claims inside and outside the multidistrict litigation (MDL), the process that places similar federal lawsuits before one judge.
AFFF contains PFAS, the so-called forever chemicals. These are manufactured compounds used in products that resist heat, stains, grease, and water, and they have been linked to liver damage, lower birth weight, reduced antibody response to vaccines, and kidney and testicular cancer.
Both releases came out after the regular session, when shares closed at $177.04, down 0.74%, for a market cap of $91,303,422,880. At 7:58 p.m. ET, after the settlement and a buyback were both announced, the stock traded at $179.00, up 1.10%.
What 3M Signed and What Still Depends on Plaintiffs
The present value of the deal, meaning what the payment stream is worth in today’s dollars, is $5.8 billion. 3M will book that amount as a pre-tax charge of $5.8 billion in the fourth quarter of 2026. The nominal total is the actual dollars paid over time, and it includes a $680 million reserve fund.
The first payment is $50 million in 2026, and nothing is due in 2027. About 20% of the money falls in the final two years.
The deal addresses about 99% of current personal injury claims, involving 115,000 to 120,000 plaintiffs. The payments depend on those plaintiffs joining, and 3M can end the deal if participation falls below a set level.
Later claimants will be handled through contingent payments and an expected court order that sets evidence and timing requirements. 3M said, “This agreement is not an admission of liability.”
How the Charge Fits Against 3M’s Cash Flow
3M said the charge “does not change 3M’s previously issued 2026 guidance,” which it raised on October 20 to adjusted EPS of $9.10 to $9.15 and adjusted free cash flow of about $4.8 billion.
Guidance holds because the charge is treated as a special item and left out of adjusted results. Fourth-quarter GAAP earnings will absorb the charge, but the cash still leaves the company.
By our calculation, the remaining $7.3 billion due from 2028 through 2034 averages $1.04 billion a year. Actual payments are uneven and higher toward the end.
As of September 30, 3M held $4.835 billion in cash and $310 million in marketable securities against $14.997 billion of debt. It had also bought $3.225 billion of its own stock in the first nine months of the year.
How 3M’s PFAS Settlements Add Up
William Brown, chairman and CEO, was upbeat. He said, “This settlement is a significant milestone for 3M and substantially reduces litigation uncertainty.”
He linked the deal to “our 2023 resolution with U.S. public water suppliers”, which has a present value of $10.3 billion and runs up to $12.5 billion over 13 years. He also pointed to New Jersey’s deal of up to $450 million through 2050. By our calculation, the three deals’ nominal commitments total $20.3 billion, but that figure mixes capped amounts and leaves out other PFAS costs.
The same afternoon, the board approved a new $6.0 billion buyback, which brings total repurchase capacity to $7.5 billion. It also declared a $0.78 dividend payable December 11. Pushing payments to the back of the schedule leaves room for buybacks now, but much of the cost falls in the next decade.
DuPont (NYSE:DD), Corteva (NYSE:CTVA) and Chemours (NYSE:CC) also face PFAS lawsuits. This deal gives the industry a reference point.
What Investors Should Track on 3M Stock
The settlement looks manageable for 3M because it has turned its largest open lawsuit into a payment schedule that averages well below this year’s free cash flow guidance, and that guidance held.
Participation risk and the debt load matter. However, 3M completed its exit from manufactured PFAS products by the end of 2025, so its production no longer adds to the problem.
3M’s investor call at 8:30 a.m. ET on Wednesday, November 4, is where to look for the participation threshold. A close above the 52-week high of $184.90 would show the market accepts the deal. A termination notice would reopen the litigation risk.
Contact [email protected] for any questions or corrections.
Omor Ibne Ehsan is a writer at 24/7 Wall St. He is a self-taught investor with a focus on growth, cyclical, and dividend equities that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as penny stocks.
